$46.36 -0.35 (-0.75%) Alkermes PLC - NASDAQ

Sep. 30, 2016 | 10:20 AM
Last Trade: 46.36
Trade Time: Sep 30 10:20 AM Eastern Daylight Time
Change: -0.35 (-0.75%)
Prev Close: 46.71
Open: 47.16
Bid: 46.34
Ask: 46.38
  1. No results found.
  1. Alkermes down after drug fails

    IBD | Jan. 21, 2016 | 18:42PM EST
  2. Mid-Afternoon Market Update: Crude Oil Surges Over 4%; Alkermes Shares Slide Following Announcement of Failed Depression Drug Trial

    Benzinga | Jan. 21, 2016 | 14:42PM EST
  3. Alkermes Hits Two-Year Low On Depression Drug Failure

    IBD | Jan. 21, 2016 | 13:02PM EST
  4. Mid-Day Market Update: US Stocks Turn Higher; Plexus Shares Gain On Strong Results

    Benzinga | Jan. 21, 2016 | 12:20PM EST
  5. Mid-Morning Market Update: Markets Drop; Verizon Profit Tops Estimates

    Benzinga | Jan. 21, 2016 | 09:55AM EST
  6. 10 Stocks Moving In Thursday's Pre-Market Session

    Benzinga | Jan. 21, 2016 | 08:19AM EST
  7. AvalonBay Communities, Equinix, Jarden, Alkermes Approach 52-Week Highs

    GuruFocus | Jan. 4, 2016 | 11:59AM EST
  8. Alkermes Reports Achievement of Milestones for CNS Medicines in Proprietary Product, Pipeline Portfolio

    Benzinga | Dec. 16, 2015 | 07:09AM EST
  9. U.S.-Traded Eurozone Stocks React Mildly To ECB Vote

    IBD | Dec. 3, 2015 | 18:11PM EST
  10. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Sep. 30, 2015 | 04:37AM EST
  11. Non-Opioid Therapeutics And Significant Pain Treatments Make For A Buy Rating

    Benzinga | Sep. 2, 2015 | 10:58AM EST
  12. Benzinga's Volume Movers

    Benzinga | Sep. 1, 2015 | 10:27AM EST
  13. Morning Market Gainers

    Benzinga | Sep. 1, 2015 | 09:44AM EST
  14. Underappreciated Leader Skips Over Equal-Weight In Double Upgrade

    Benzinga | Sep. 1, 2015 | 09:04AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 1, 2015 | 08:13AM EST
Trading Center